ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Rui-hua Xu, MD, PhD · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
esophageal-squamous-cell-carcinoma
esophageal cancer, liposomal irinotecan, second-line therapy, esophageal squamous cell carcinoma, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 914641
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.